600594 Guizhou Yibai Pharmaceutical
- 4.14
- +0.04+0.98%
Guizhou Yibai Pharmaceutical News
Announcement of Guizhou Yibai Pharmaceutical Co., Ltd. Regarding the Provision of Impairment Loss Reserves for Relevant Assets in the First Half of 2024
Announcement of Resolutions from the First Extraordinary Shareholders' Meeting of Guizhou Yibai Pharmaceutical Co., Ltd. in 2024.
Legal Opinion on the First Extraordinary General Meeting of Shareholders of Guizhou Yibai Pharmaceutical Co., Ltd. in 2024 by Junzhi Law Firm in Peking.
Guizhou Yibai Pharmaceutical Co., Ltd. 2024 First Extraordinary General Meeting of Shareholders Meeting Data
Announcement of Guizhou Yibai Pharmaceutical Co., Ltd. on the situation explanation of the situation relating to the centralized procurement of proprietary Chinese medicines such as Qingkailing in Guangdong Union
Announcement of Guizhou Yibai Pharmaceutical Co., Ltd. on changes in the company's supervisors
Notice of Guizhou Yibai Pharmaceutical Co., Ltd. on convening the first extraordinary general meeting of shareholders in 2024
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Guizhou Yibai Pharmaceutical Co., Ltd
Legal Opinion of Beijing Junzhi Law Firm on the 2023 Annual General Meeting of Shareholders of Guizhou Yibai Pharmaceutical Co., Ltd.
Guizhou Yibai Pharmaceutical Co., Ltd. 2023 Annual General Meeting of Shareholders Meeting Materials
Announcement of Guizhou Yibai Pharmaceutical Co., Ltd. on the resignation of the company's independent director
Announcement of Guizhou Yibai Pharmaceutical Co., Ltd. on calculating depreciation preparations for relevant assets for 2023
Notice of Guizhou Yibai Pharmaceutical Co., Ltd. on convening the 2023 Annual General Meeting of Shareholders
Guizhou Yibai Pharmaceutical Co., Ltd. 2023 Internal Control Evaluation Report
Report on the performance of the Audit Committee of the Board of Directors of Guizhou Yibai Pharmaceutical Co., Ltd. in 2023
Report of the Audit Committee of the Board of Directors of Guizhou Yibai Pharmaceutical Co., Ltd. on the performance of supervisory duties by the accounting firm in 2023
Announcement of Guizhou Yibai Pharmaceutical Co., Ltd. on the annual change of quality control reviewers by the auditing agency
Announcement of Guizhou Yibai Pharmaceutical Co., Ltd. on the resignation of the company\'s deputy general manager and board secretary
Announcement of Guizhou Yibai Pharmaceutical Co., Ltd. on the resignation of the company\'s vice chairman and co-president
Announcement of Guizhou Yibai Pharmaceutical Co., Ltd. on changing the signed certified public accountant and quality control reviewer
Analysis
Price Target
No Data
No Data